Early changes in tubular dysfunction markers and phosphorus metabolism regulators as a result of switching from entecavir to tenofovir alafenamide fumarate nucleoside analog therapy for chronic hepatitis B patients. Issue 3 (6th March 2020) - Notsumata, Kazuo; Nomura, Yoshimoto; Tanaka, Akihiro; Ueda, Teruyuki; Sanada, Taku; Watanabe, Hiroyuki; Toya, Daishu